NIRAPARIB vs NIRSEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRAPARIB vs NIRSEVIMAB: Safety Overview
| Metric | NIRAPARIB | NIRSEVIMAB |
|---|---|---|
| Total FAERS Reports | 21,634 | 247 |
| Deaths Reported | 1,370 | 5 |
| Death Rate | 6.3% | 2.0% |
| Hospitalizations | 4,892 | 149 |
| Average Patient Age | 65.7 yrs | 0.3 yrs |
| % Female Patients | 98.5% | 42.3% |
| FDA Approval Date | Apr 26, 2023 | N/A |
| Manufacturer | GlaxoSmithKline LLC | Sanofi Pasteur Inc. |
| Route | ORAL | INTRAMUSCULAR |
| Marketing Status | Discontinued | N/A |